Combination of Detoxified Pneumolysin Derivative ΔA146Ply and Berbamine as a Treatment Approach for Breast Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combination of Detoxified Pneumolysin Derivative ΔA146Ply and Berbamine as a Treatment Approach for Breast Cancer

Published:2020-09 Issue: Volume:18 Page:247-261
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Zhang Hong,Zhu Tao,Fu Ruoqiu,Peng Yang,Jing Peng,Xu Wenchun,Wang Hong,Li Sijie,Shu Zhaoche,Yin Yibing,Zhang Xuemei

Funder

National Natural Science Foundation

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference59 articles.

1. Breast cancer;Harbeck;Lancet,2017

2. Global cancer statistics, 2012;Torre;CA Cancer J. Clin.,2015

3. Cancer statistics in China, 2015;Chen;CA Cancer J. Clin.,2016

4. Epithelial-mesenchymal transition and drug resistance in breast cancer (Review);Huang;Int. J. Oncol.,2015

5. Classification, Treatment Strategy, and Associated Drug Resistance in Breast Cancer;Tang;Clin. Breast Cancer,2016

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Berbamine inhibits porcine epidemic diarrhea virus in vitro and in vivo;Veterinary Microbiology;2024-11

2. From immune checkpoints to therapies: understanding immune checkpoint regulation and the influence of natural products and traditional medicine on immune checkpoint and immunotherapy in lung cancer;Frontiers in Immunology;2024-02-15

3. Detoxified pneumolysin derivative ΔA146Ply inhibits triple- negative breast cancer metastasis mainly via mannose receptor-mediated autophagy inhibition;Virulence;2023-11-15

4. Antidiabetic activity of Berberis brandisiana is possibly mediated through modulation of insulin signaling pathway, inflammatory cytokines and adipocytokines in high fat diet and streptozotocin-administered rats;Frontiers in Pharmacology;2023-04-06

5. Berberis aristata and its secondary metabolites: Insights into nutraceutical and therapeutical applications;Pharmacological Research - Modern Chinese Medicine;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3